echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Research progress of endovascular treatment for high-risk non-acute internal carotid artery occlusion

    Research progress of endovascular treatment for high-risk non-acute internal carotid artery occlusion

    • Last Update: 2021-12-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Non-acute internal carotid artery occlusion (NA-ICAO) currently includes conservative medication, bypass surgery, carotid endarterectomy (CEA), and endovascular treatment.
    treatment, EVT)
    .

    01 Development of Endovascular Therapy In 2005, Terada and others applied the proximal blood flow reversal protection technology for the first time, successfully recanalizing the first NA-ICAO patient's blood vessel, and there was no distal embolism or bleeding during and after the operation.


    Complications


    02 Preoperative evaluation dimensions and methods of endovascular treatment

    There is still no conclusive decision on the precise selection of EVT treatment of NA-ICAO.


    At present, EVT treatment is mostly targeted at high-risk NA-ICAO patients who are symptomatic and still have stroke after drug treatment
    .


    There is still no conclusive decision on the precise selection of EVT treatment of NA-ICAO.


    03 Safety of endovascular treatment Previous studies have shown that the complication rate of EVT treatment of NA-ICAO varies greatly among research centers
    .


    Literature source:

    Chinese Stroke Journal, Volume 16, Issue 10, October 2021

    Chinese Stroke Journal, Volume 16, Issue 10, October 2021

     

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.